2023 Full Year Guidance

Reconciliation of GAAP to non-GAAP financial measures Shareholders' net income and diluted earnings per share Year Ended December 31, 2022 Shareholders' net income Adjustments to reconcile to Dollars in millions Pre-Tax Diluted earnings per share Dollars in millions Diluted earnings per share Pre-Tax After-Tax After-Tax $6,668 $21.30 adjusted income from operations: Net realized investment losses* $621 $1.98 $503 $1.61 Amortization of acquired $1,876 $5.99 $1,345 $4.30 intangible assets Special items Integration and transaction-related costs $135 $0.43 $103 $0.33 Charge for organizational efficiency plan $22 $0.07 $17 $0.05 (Benefits) associated with litigation matters $(28) $(0.09) $(20) $(0.06) (Gain) on sale of business $(1,662) $(5.31) $(1,332) $(4.26) Adjusted income from operations $7,284 $23.27 *Includes the Company's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting. Confidential, unpublishedproperty of Cigna. © 2023 Cigna

View entire presentation